Celldex Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Celldex Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Celldex Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $9.62M, a 35.1% increase year-over-year.
  • Celldex Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $31.7M, a 49.5% increase year-over-year.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $23.9M, a 53% increase from 2022.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.6M, a 74.4% increase from 2021.
  • Celldex Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.95M, a 129% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $31.7M $9.62M +$2.5M +35.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $29.2M $7.64M +$2.42M +46.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $26.8M $7.2M +$2.86M +65.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $23.9M $7.21M +$2.7M +60% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $21.2M $7.12M +$2.63M +58.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $18.6M $5.22M +$1.76M +51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $16.8M $4.34M +$1.19M +37.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $15.6M $4.51M +$1.37M +43.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $14.2M $4.5M +$1.47M +48.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $12.8M $3.45M +$1.95M +129% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $10.8M $3.15M +$1.88M +147% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $8.95M $3.14M +$1.88M +150% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $7.07M $3.03M +$1.78M +142% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.29M $1.51M +$787K +109% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $4.5M $1.28M +$588K +85.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $3.92M $1.26M +$569K +82.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $3.35M $1.25M +$543K +76.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $2.8M $722K -$742K -50.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.55M $687K -$1.01M -59.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4.55M $687K -$1.07M -60.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $5.62M $707K -$1.09M -60.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.7M $1.46M -$584K -28.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $7.29M $1.69M -$795K -32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $8.08M $1.75M -$832K -32.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-29
Q3 2018 $8.91M $1.79M -$946K -34.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $9.86M $2.05M -$1.4M -40.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $11.3M $2.49M -$1.05M -29.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $12.3M $2.58M -$1.02M -28.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 $13.3M $2.74M -$1.06M -27.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $14.4M $3.45M -$523K -13.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $14.9M $3.54M -$401K -10.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.3M $3.61M -$490K -12% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $15.8M $3.8M -$72K -1.86% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $15.9M $3.97M +$1.45M +57.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $14.4M $3.94M +$1.66M +72.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $12.8M $4.1M +$1.97M +92.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 $10.8M $3.87M +$1.91M +97.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $8.9M $2.53M +$1.02M +67.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $7.88M $2.28M +$1.03M +82.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $6.85M $2.13M +$985K +85.8% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 $5.87M $1.96M -$58K -2.88% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $5.93M $1.51M +$835K +124% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $5.09M $1.25M +$542K +76.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $4.55M $1.15M +$464K +67.8% Oct 1, 2013 Dec 31, 2013 10-K/A 2016-02-25
Q3 2013 $4.08M $2.02M +$1.49M +284% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $2.59M $676K +$228K +50.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.37M $708K +$67K +10.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $2.3M $684K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $525K -$45K -7.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $448K -$105K -19% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $641K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q3 2011 $570K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 $553K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.